To evaluate the therapeutic effectiveness of the compounds as inhibitors of cholinesterases, the reported procedures were followed (Elman's protocol) [31 ]. Enzymes acetylcholinesterase (EC 3.1.1.7) and butyrylcholinesterase (EC 3.1.1.8) were purchased from local market.
The acetylcholinesterase inhibition assay is based on the principle of the hydrolytic breakdown of substrate; acetylthiocholine iodide by acetylcholinesterase enzyme. The AChE acts on acetylthiocholine to thiocholine which then react with DTNB that's leads towards the formations of anion (5-thio-2-nitrobenzoate) a yellow colour product which is then assessed via UV visible spectrophotometer at 405 nm [32 ].
The AChE, Ellman's Reagent (DTNB) and acetylthiocholine iodide (ATChI, substrate), and the test compound solutions were made in different concentrations ranges from (0.01–1.0 μM) were incubated per detail given in the Ellman's protocol. Galantamine was employed as the reference drug [33 (link),34 ]. IC50 of each Schiff bases were calculated using Microsoft Excel 2013 software.
In similar fashion following BChE, Ellman's Reagent (DTNB) and butyryl thiocholine iodide (BTChI, substrate), and the test compound Schiff bases solutions were made in different concentrations ranges from (0.01–1.0 μM) were incubated following the standard protocol. The absorbance at 405 nm was measured and the data were analysed in triplicate. Galantamine was employed as standard drug [33 (link),34 ].
Free full text: Click here